Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040
Deependra Singh, Salvatore Vaccarella, Andrea Gini, et al.
International Journal of Cancer (2022) Vol. 150, Iss. 12, pp. 1941-1947
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Shanqiang Qu, Rongyang Xu, Guozhong Yi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 19
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
Chutong Tian, Shunzhe Zheng, Xinying Liu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 59
Injectable Carbon Dots-Based Hydrogel for Combined Photothermal Therapy and Photodynamic Therapy of Cancer
Juan Yue, Peng Miao, Li Li, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 44, pp. 49582-49591
Closed Access | Times Cited: 49
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research
Xingxing Liu, Qiuping Su, Xiaoyu Zhang, et al.
Biosensors (2022) Vol. 12, Iss. 11, pp. 1045-1045
Open Access | Times Cited: 42
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 38
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 12
Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN
Jialin Zhou, Ying Xu, Jianmin Liu, et al.
Cancer Epidemiology (2024) Vol. 93, pp. 102693-102693
Open Access | Times Cited: 12
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9795-9811
Closed Access | Times Cited: 21
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 17
Blocking Fusobacterium nucleatum-host cell interactions with responsive supramolecular GalNAc-derived nanoplatform for enhanced chemotherapy in colorectal cancer
T.-C. Wu, Danyang Jin, Mengdi Wu, et al.
Nano Today (2024) Vol. 56, pp. 102288-102288
Closed Access | Times Cited: 6
Breast cancer; epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting
Ibrahim Mohamed, Zeinab Fathalla, Adel Al Fatease, et al.
Expert Opinion on Drug Delivery (2024)
Closed Access | Times Cited: 4
“Innate Immune Cell Engagers: Matchmakers for Next-Generation Immunotherapy”
Sascha Cording, Jens Pahl, Kristina Ellwanger, et al.
Springer eBooks (2025), pp. 1-25
Closed Access
Causal Associations of Gut Microbiota Species With Lymphoma: A Two‐Sample Mendelian Randomization Study
Mei Li, Li Wang, Zhong‐Ren Peng, et al.
Hematological Oncology (2025) Vol. 43, Iss. 2
Closed Access
Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022
Kexin Sun, Hongliang Wu, Qian Zhu, et al.
EClinicalMedicine (2025) Vol. 83, pp. 103193-103193
Closed Access
Development of a Prediction Model for Hyperthermia-Enhanced Drug Delivery using Thermosensitive Nanoparticles
Fatemeh Bahrami Einolghasi, Behnam Zeinali, Kambiz Vafai, et al.
Journal of Thermal Biology (2025) Vol. 129, pp. 104124-104124
Closed Access
Comparing Hodgkin and Non-Hodgkin Lymphoma Mortality Between Latin America and the United States From 2008 to 2019: The Need of Regional-Based Lymphoma Registries
Bryan Valcárcel, German R. Stemmelin, Sofía Gabriela Rivarola, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
Investigation of the female infertility risk associated with anti-cancer therapy
Atiye Lavafian, Parmida Sadat Pezeshki, Nima Rezaei
Clinical & Translational Oncology (2023) Vol. 25, Iss. 7, pp. 1893-1905
Closed Access | Times Cited: 7
Exposure to pesticides and risk of Hodgkin lymphoma in an international consortium of agricultural cohorts (AGRICOH)
Joanne Kim, Maria E. Leon, Leah H. Schinasi, et al.
Cancer Causes & Control (2023) Vol. 34, Iss. 11, pp. 995-1003
Open Access | Times Cited: 7
Medicinal plants used in the management of cancers by residents in the Elgon Sub-Region, Uganda
Ali Kudamba, Josephine Kasolo, Godfrey S. Bbosa, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Fabrication and Evaluation of Anticancer Potential of Eugenol Incorporated Chitosan-Silver Nanocomposites: In Vitro, In Vivo, and In Silico Studies
Hamid Saeed Shah, Sumera Zaib, Muhammad Sarfraz, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 5
Computational molecular perspectives on novel carbazole derivative as an anti-cancer molecule against CDK1 of breast and colorectal cancers via gene expression studies, novel two-way docking strategies, molecular mechanics and dynamics
Eashita Suvarna, Anagha S Setlur, K Chandrashekar, et al.
Computational Biology and Chemistry (2023) Vol. 108, pp. 107979-107979
Closed Access | Times Cited: 4
Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population
Beatriz Núñez, M. Blanco Clemente, Juan Cristóbal Sánchez, et al.
Hematological Oncology (2023) Vol. 41, Iss. 3, pp. 407-414
Open Access | Times Cited: 4
Treatment approaches for older Hodgkin lymphoma patients
Paul J. Bröckelmann
Current Opinion in Oncology (2024) Vol. 36, Iss. 5, pp. 353-359
Closed Access | Times Cited: 1
Development and validation of a geographic search filter for MEDLINE (PubMed) to identify studies about Germany
Alexander Pachanov, Catharina Muente, Julian Hirt, et al.
Research Synthesis Methods (2024) Vol. 15, Iss. 6, pp. 1147-1160
Open Access | Times Cited: 1
Classic Hodgkin lymphoma in young people
Srishti Gupta, Jeffrey W. Craig
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 6, pp. 379-391
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top